F

Fidelity Investments

Manages investments and workplace retirement plans

Vice President Private Wealth Management Leader

Full-TimeUpdated on 10/22/2026
$96k - $210k/yr
Senior
Bachelor's
New York, NY, USA
In PersonAbility to travel locally and regionally.
Finance & BankingWealth Management & Financial Advisory
No H1B Sponsorship

About the job

Requirements
  • An active Series 7 (General Securities), Series 9/10 (General Supervisory Principal), and Series 66 (Investment Advisor) license is required.
  • A bachelor's degree is required.
  • A minimum of 5+ years of relevant financial services and leadership experience is required.
  • A proven track record of building and developing high-performing, dispersed, client-facing teams is required.
  • Experience in the high-net-worth space, including managing complex wealth management client issues and escalations, is required.
  • Knowledge of institutional sales and relationship management, wealth planning, and benefits guidance is required.
  • A solid understanding of high-net-worth products and services, consultative skills, and planning and guidance tools is required.
  • The ability to build strategic partnerships at any level within and outside the firm is required.
  • The ability to navigate a complex, multi-level business environment and deliver results is required.
  • The ability to work autonomously and through ambiguity while managing multiple conflicting priorities is required.
  • The ability to plan, organize, and manage time effectively is required.
  • The ability to travel locally and regionally is required.
Responsibilities
  • Build and develop a high-performing Wealth Management Advisor team through talent acquisition, hiring, onboarding, coaching, and performance management.
  • Establish clear performance expectations and accountability standards, and conduct regular performance reviews and practice reviews.
  • Foster collaboration, professionalism, a strong work ethic, and continuous improvement across teams.
  • Enable high-performing Private Wealth Management teams through resource utilization and collaboration with regional leadership teams to promote alignment.
  • Be accountable for overall business results within the territory covered by the teams, including customer loyalty, assets under administration and assets under management growth, and client engagement.
  • Ensure effective adoption and implementation of technology, training, and new initiatives and priorities.
  • Ensure compliance with regulatory requirements, perform periodic reviews, and provide oversight for audit-related issues.
  • Support cross-Wealth and cross-company partnerships designed to drive additional business opportunities and growth.
Desired Qualifications
  • An advanced degree is preferred.
  • A Certified Financial Planner (CFP), Chartered Financial Analyst (CFA), or equivalent credential is recommended.
  • Bonus or other variable compensation may be included in the offer package, depending on position and eligibility.

About the company

Fidelity Investments manages money and runs brokerage accounts for individuals, while administering workplace benefits and supporting financial advisers and institutions. Its funds span active management and index investing, and its advice services range from automated portfolios to dedicated wealth managers. Customers trade through online accounts or work with advisers by phone and at investor centers, while employers use its services for retirement savings and stock plans. The business earns advisory fees and charges for selected trades, with institutional custody and clearing services alongside its consumer accounts. Fidelity was founded in 1946 and is headquartered in Boston, Massachusetts, United States.

Company Size

10,001+

Company Stage

Debt Financing

Total Funding

$247.8B

Headquarters

Boston, Massachusetts

Founded

1946

Get referred to Fidelity Investments

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Growth supports business investment: March 2026 reporting showed Fidelity's 2025 revenue rose 15% to $37.7 billion.
  • Eligible US employees build retirement savings: Fidelity combines a 401(k) match with annual profit sharing.
  • Investment teams gained product scope: Fidelity launched four active small and midcap ETFs in April 2026.

What critics are saying

  • Technology careers face restructuring: Fidelity cut about 800 jobs in its technology and product overhaul in May 2026.
  • Boston staff face less flexibility: April 2026's policy sets five office days from September, with phone-support exemptions.
  • Custody teams face irreversible errors: Fidelity's bitcoin fund warns lost private keys without backups permanently strand assets.

What makes Fidelity Investments unique

  • Public shareholders do not set Fidelity's agenda: the investment group remains privately held.
  • Fidelity competes on fund costs: its four ZERO index mutual funds charge no expense ratio.
  • Platform scale supports large projects: Fidelity reported $18 trillion under administration for year-end 2025 in March 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Mental Health Support
  • Hybrid Work Options
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Unlimited Paid Time Off
  • Parental Leave
  • Student Loan Assistance
  • Tuition Reimbursement

Company News

Yahoo Finance
Oct 22nd, 2026
Fidelity's Timmer says AI bubble risk lies in debt, as CoreWeave bond yields top 15%

Fidelity's director of global macro, Jurrien Timmer, says any AI bubble may sit in debt markets rather than stocks. Yields on bonds from AI cloud provider CoreWeave topped 15% last week, even as equity valuations fall. Timmer compared CoreWeave's yield with a Bloomberg index of junk-rated telecom bonds from the 1998 to 2000 boom. In that era, the warning came from debt, not dot-com stocks. Highly rated AI borrowers still look stable, he said. CoreWeave's 2031 notes yielded 15.78% last Thursday. Its debt rose from $21 billion at the end of 2025 to $35 billion by June 30, and net interest expense of $640 million took about a quarter of second-quarter revenue. Chief executive officer Mike Intrator said its backlog, near $104 billion, more than covers its debt.

Business Wire
Oct 16th, 2026
Newsroom | Business Wire

The global leader in press release distribution and regulatory disclosure. Public relations and investor relations professionals rely on Business Wire for broad-based and targeted market reach.

IT桔子
Oct 15th, 2026
Veir raises $24.9M Series A+ for high-temperature superconductor power transmission

US startup Veir has raised $24.9 million in a Series A+ round. VXI Capital, Galvanize Climate Solutions, Fidelity Investments, Congruent Ventures, The Engine, and Breakthrough Energy Ventures invested. Veir develops a way to transmit electricity using high-temperature superconductors (HTS). Its platform uses evaporative cryogenic cooling. The technology lets utilities carry more power at lower voltage within a smaller right-of-way. This helps connect the lowest-cost renewable resources to the places that need them.

Business Wire
Oct 13th, 2026
Inscripta Announces the First Commercial Shipment of Its Onyx™ Digital Genome Engineering Platform and Closes $150 Million in New Financing

Financing round led by Fidelity and T. Rowe Price funds underscores vast opportunities to bring Inscripta’s technology to the broader bioeconomy.

Morningstar
Oct 13th, 2026
Soufflé Therapeutics raises $135M Series B led by Juvia Group for muscle and heart RNA therapies

Soufflé Therapeutics has closed an oversubscribed $135 million Series B round led by Juvia Group. New investors include TCG Crossover Management, BB Biotech, Fidelity Management & Research Company, Balyasny Asset Management, and a sovereign wealth fund. Existing backers such as Amgen Ventures, ARCH Venture Partners, and Temasek also took part. The RNA therapies company will use the money to move its three lead programs into clinical studies. They target facioscapulohumeral muscular dystrophy (FSHD), heart failure with reduced ejection fraction, and muscle and metabolic disorders. It will also advance its pipeline in other cell types and tissues. Its REMEDY (Receptor Mediated Delivery) engine delivers oligonucleotide therapies to specific cells outside the liver. "This exceptional group of investors" backs the engine's potential, said chief executive officer Amir Nashat.